Journal
PROSTATE CANCER AND PROSTATIC DISEASES
Volume 9, Issue 3, Pages 293-297Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.pcan.4500872
Keywords
alpha s1-casein; marker; diagnosis; benign prostate hyperplasia
Categories
Ask authors/readers for more resources
Benign prostate hyperplasia (BPH) is a common disease in elderly men. Although it is a nonmalignant disease, it has a significant detrimental impact on the quality of life in patients with late-stage disease. Owing to the lack of specific markers, diagnosis of early-stage BPH has been proven unsuccessful. Recently, using two-dimensional electrophoresis, we identified a group of prostatic secretory proteins that are specifically produced by BPH cells (Xu et al., Electrophoresis 2003; 24: 1311). In this study, we investigated the potential diagnostic value of one of the secretory proteins, alpha s1-Casein, in BPH by inmmunohistological staining of normal, BPH and prostate cancer tissues. We found that 90% ( 20 out of 22) of BPH tissues showed moderate to strong alpha s1-Casein protein expression whereas none of the normal tissues ( 0 out of 10) and less than 10% of the prostate cancer tissues ( 3 out of 30) showed similar staining intensity. Our results suggest that alpha s1-Casein may be a potential biomarker for early identification of BPH patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available